Company K Partners

Established in 2006, Company K Partners is a principal investment firm headquartered in Gyeonggi-do, South Korea. It specializes in investments across various industries including culture content, electronic components, machinery, broadcasting, arts, sports, and leisure.

Jae Won D

Principal

Past deals in South Korea

Medipixel

Series B in 2023
Medipixel, Inc. is a South Korean MedTech startup founded in 2017, specializing in artificial intelligence-based diagnostic software and semi-autonomous robotic systems for lung cancer and cardiac interventions. The company is comprised of a team of AI experts in computer vision, deep learning, and reinforcement learning, collaborating with top healthcare professionals, including those at Seoul Asan Medical Center, to enhance disease diagnosis and surgical procedures. Medipixel offers three primary solutions for intervention surgeons: an AI-based diagnosis tool that assists in identifying lesions during coronary angiography, a guide and planning solution that visualizes coronary arteries to facilitate guidewire manipulation, and an automated navigation engine that directs robotic units through arteries with real-time commands. These innovations aim to improve surgical outcomes and patient safety by reducing reliance on contrast agents and enhancing the precision of interventions.

Fadu

Venture Round in 2023
FADU Inc. is a fabless semiconductor company specializing in innovative memory and storage solutions. Established in 2015 and headquartered in Seoul, South Korea, with an additional office in Mountain View, California, FADU focuses on developing advanced Flash storage technology and architecture. The company's product lineup includes the FADU Annapurna and FADU Bravo SSD controllers, which are designed to meet the increasing data demands in enterprise data centers. With a team comprised of skilled architects, ASIC experts, and seasoned engineers from leading firms, FADU aims to introduce next-generation products that will redefine standards within the industry. As a newcomer in this competitive field, FADU is committed to leveraging innovative ideas to address the challenges posed by rapidly evolving data requirements.

LUNASOFT

Venture Round in 2022
LUNASOFT INC. is a South Korean company founded in 2016, specializing in the development of chatbots and integrated management platforms aimed at enhancing customer support. The company offers a range of solutions, including Luna Plus, a courier exchange platform; Luna Plus Mobile, which facilitates real-time business consultations; and Luna Plus CTI, a customer counseling platform that combines phone and intelligent chat counseling. Additionally, LUNASOFT develops customer consultation chatbots tailored for popular messaging platforms such as Naver and Kakao, primarily catering to e-commerce businesses. Based in Seoul, LUNASOFT is focused on providing innovative chat solutions to improve customer interaction and support processes.

Spark Biopharma

Series C in 2022
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring and developing new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. '

Neosapience

Series B in 2022
Neosapience, Inc. is a South Korean company specializing in artificial intelligence-driven voice synthesis and avatar technologies. Founded in 2017 and headquartered in Seoul, the company has developed innovative products like Icepeak.AI and Typecast, which allow users to generate speech that closely mimics individual voice characteristics, including prosody and emotion. Icepeak.AI is an online platform that learns and replicates voice features, while Typecast, launched in 2019, has gained popularity as an AI-powered content creation service, used by over 2 million users across 225 countries. Additionally, Neosapience offers a mobile application, ICEPEAK, enabling users to create personalized voice interactions. The company aims to redefine content creation through advanced AI technologies, making voice-over processes more accessible and efficient.

Organoid Sciences

Series B in 2022
Organoid Sciences is a biotechnology company founded in 2018 and located in Seongnam-si, South Korea. The company specializes in developing organoid-based therapies using its proprietary Keo cannabinoid technology to address various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, aiming to advance treatment options through innovative approaches.

afun interactive

Series B in 2021
Afun Interactive Inc. is a virtual reality company based in Seoul, South Korea, founded in 2016 by Han Yu. The company specializes in three-dimensional rendering technologies and focuses on the production and distribution of real-time content for various applications, including augmented reality and virtual reality. Afun Interactive creates digital content tailored to the specific needs of its clients, serving the entertainment industry by providing high-quality animations and graphics for movies and games. Through its innovative approach, the company aims to deliver immersive experiences and enhance the visual storytelling capabilities of its partners.

Bankware Global

Series B in 2021
Founded in 2010 and headquartered in Seoul, Korea, Bankware Global specializes in the development of banking and financial software systems tailored for various sectors, including retail, corporate, private, treasury, and microfinance banks. With a presence in three countries and four offices, the company serves over 100 financial institutions across seven countries in the Asia Pacific region. Bankware Global is recognized for its expertise in core banking solutions, having supplied its software to five digital banks in markets such as Korea, China, Japan, and Taiwan. The company is distinguished as a leading provider of core banking solutions in Korea, focusing on delivering innovative financial institution products and transaction software to both domestic and international clients.

Return Zero

Series B in 2021
Return Zero, Inc. is a technology company based in Seoul, South Korea, founded in 2011. It specializes in developing an artificial intelligence-based voice recognition application that transforms phone conversations into text messages. The company's innovative application converts audio phone messages into messenger text, facilitating seamless communication. With a focus on advanced speech recognition and machine learning, Return Zero aims to enhance the accessibility and usability of voice interactions in digital messaging.

Kmong

Series C in 2021
Kmong Inc. is a South Korean company that operates a freelance and micro-job marketplace, facilitating the exchange of services between individuals. Established in June 2012, the platform allows users to buy and sell a wide range of services across various categories, including design, IT and programming, marketing, consulting, translation, writing, and more. Freelancers can list their services with price quotes, making it easier for potential clients to find and engage with them. Kmong's services extend beyond traditional categories to include offerings like private lessons and unique personal services. The company is based in Seoul and provides a mobile application for Android devices, enhancing accessibility for users.

TCUBEit

Venture Round in 2021
TCUBEit Inc. is a biotechnology company based in Sejong, South Korea, with an additional location in Cheongju. Founded in 2019, TCUBEit specializes in T cell-based immunotherapy, focusing on the collection and organization of T cells from patients. The company is dedicated to enhancing both the quantity and quality of T cells, which play a crucial role in identifying and eliminating cancers and infections within the human body. Through its research and product development efforts, TCUBEit aims to advance the discovery and commercialization of personalized therapeutic cell-based therapies, contributing to the field of cancer immunotherapy.

Watcha

Venture Round in 2020
WATCHA, Inc. is a South Korean company founded in 2011 and headquartered in Seoul, specializing in online interactive media services. It initially gained popularity as a movie review application, becoming a favorite in Korea for its personalized recommendation technology. Users rate movies, allowing WATCHA to predict their preferences for unseen films. In addition to its review platform, WATCHA launched a subscription video-on-demand service called WATCHA PLAY in 2016, which offers a wide selection of movies and TV series accessible across various devices, including web browsers, mobile platforms, and smart TVs. The service is noted for its highly accurate content recommendations, with a significant portion of consumed content driven by these suggestions. WATCHA has also expanded its presence internationally, having launched in Japan in 2015.

HaplnScience

Seed Round in 2020
HaplnScience is a pharmaceutical company established in 2018 and based in Seongnam-si, Gyeonggi-do, South Korea. The company specializes in developing innovative anti-aging therapies aimed at reversing tissue and organ degeneration. Utilizing HAPLN1, a novel protein, HaplnScience's research focuses on strengthening the extracellular matrix to halt the aging process. Their drug formulations are designed to prevent the degeneration of bodily tissues, effectively addressing issues such as skin aging, hair aging, and osteoarthritis. By advancing these therapeutic solutions, HaplnScience aims to significantly enhance the health and quality of life for the elderly.

Olix Pharmaceuticals

Post in 2020
OliX Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Suwon, South Korea, dedicated to developing RNA interference (RNAi) therapeutics targeting various dermal, ophthalmic, and pulmonary diseases. The company’s product pipeline includes OLX101 for skin scarring, OLX102 for skin whitening, OLX103 for atopic dermatitis, OLX104 for hair loss, OLX105 for anti-wrinkle treatments, and OLX106 for diabetic foot ulcers. Additionally, it is developing OLX301 for age-related macular degeneration, OLX304 for retinitis pigmentosa, OLX201 for lung fibrosis, OLX202 for asthma, OLX203 for influenza, OLX401 for neuropathic pain, OLX701 for liver fibrosis, and OLX701 for cancer immunotherapy. The company has also entered into a collaboration agreement with Théa to advance SiRNA therapeutics for ophthalmic conditions. Founded in 2010, OliX Pharmaceuticals leverages its proprietary RNAi technology to regulate the expression of genes associated with various diseases.

My Franchise

Series A in 2020
My Franchise is a company founded in 2019 in Seoul, South Korea, that focuses on bridging the gap between franchise headquarters and prospective founders. It has developed an online platform that serves as a resource for these two parties, facilitating a partnership that is mutually beneficial. The platform provides valuable startup information, such as the number of franchisees over the years, average sales figures, and the associated startup costs of domestic franchise brands. This allows prospective founders to effectively compare and analyze important brand information, categorized by industry, helping them make informed decisions in their franchise endeavors.

Wave

Series B in 2020
Wave Corporation, founded in 2018 and based in South Korea, develops a mobile video chat application designed to enhance social interactions among users. The application enables individuals to create chat rooms where they can engage in group video chats, play live party games, watch video clips, read webtoons, and share photos. By facilitating these activities, Wave aims to reduce the distance between people, allowing friends to connect and interact in a more engaging and entertaining manner.

Nearthlab

Series B in 2020
Nearthlab is a Seoul-based technology company that designs and develops autonomous drone systems and AI-powered software for safety inspections in wind and renewable energy sectors, with applications also in defense and public safety. Its products include NearthWIND Pro, an autonomous drone for wind turbine inspection; Zoomable, a cloud-based data platform for inspection data management and analysis; and NearthWIND Mobile, a mobile autonomous flight control solution. The company uses proprietary deep-learning algorithms enabling autonomous flight under low computing power and low-latency conditions, aiming to reduce inspection time from hours to minutes. It holds multiple patents in Korea and overseas and has received venture backing from leading Korean investors.

Organoid Sciences

Series A in 2020
Organoid Sciences is a biotechnology company founded in 2018 and located in Seongnam-si, South Korea. The company specializes in developing organoid-based therapies using its proprietary Keo cannabinoid technology to address various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, aiming to advance treatment options through innovative approaches.

RIDI

Series E in 2020
RIDI Corporation is South Korea’s one of the largest digital content publication & distribution companies, mainly known for vitalizing the Korean e-book industry as well as empowering the web novel, webcomic, animation, articles, and news media. RIDI believes that rich imagination and deep insight serve as nutrients to make the human mind fertile and delivers them through its digital contents.

Neosapience

Series A in 2020
Neosapience, Inc. is a South Korean company specializing in artificial intelligence-driven voice synthesis and avatar technologies. Founded in 2017 and headquartered in Seoul, the company has developed innovative products like Icepeak.AI and Typecast, which allow users to generate speech that closely mimics individual voice characteristics, including prosody and emotion. Icepeak.AI is an online platform that learns and replicates voice features, while Typecast, launched in 2019, has gained popularity as an AI-powered content creation service, used by over 2 million users across 225 countries. Additionally, Neosapience offers a mobile application, ICEPEAK, enabling users to create personalized voice interactions. The company aims to redefine content creation through advanced AI technologies, making voice-over processes more accessible and efficient.

Nunaps

Series A in 2020
Nunaps, Inc. is a digital therapeutics startup founded in 2017 and based in Seoul, South Korea. The company focuses on designing and developing digital therapeutic devices aimed at improving brain disease disorders. Its product offerings include NUNAP vision, a 3-D training method that addresses visual disturbances; NUNAP pain; and NUNAP hearing. Nunaps employs a unique platform that identifies target biomarkers and utilizes principles of visual perception training to enhance brain connectivity in the visual pathway. By leveraging specific visual stimuli, the company aims to help patients manage and treat various neurological disorders, ultimately enhancing their ability to perceive and interact with their surroundings.

Return Zero

Venture Round in 2020
Return Zero, Inc. is a technology company based in Seoul, South Korea, founded in 2011. It specializes in developing an artificial intelligence-based voice recognition application that transforms phone conversations into text messages. The company's innovative application converts audio phone messages into messenger text, facilitating seamless communication. With a focus on advanced speech recognition and machine learning, Return Zero aims to enhance the accessibility and usability of voice interactions in digital messaging.

RIDI

Series E in 2019
RIDI Corporation is South Korea’s one of the largest digital content publication & distribution companies, mainly known for vitalizing the Korean e-book industry as well as empowering the web novel, webcomic, animation, articles, and news media. RIDI believes that rich imagination and deep insight serve as nutrients to make the human mind fertile and delivers them through its digital contents.

KoBioLabs

Venture Round in 2019
KoBioLabs, Inc. is a biotechnology company based in Seoul, South Korea, specializing in microbiome therapeutics. The company focuses on developing innovative treatments for a range of health conditions, including metabolic, immune, and neurological diseases. Through its research efforts, KoBioLabs aims to harness the potential of the microbiome to create effective medicinal solutions that address these critical areas of human health.

afun interactive

Venture Round in 2019
Afun Interactive Inc. is a virtual reality company based in Seoul, South Korea, founded in 2016 by Han Yu. The company specializes in three-dimensional rendering technologies and focuses on the production and distribution of real-time content for various applications, including augmented reality and virtual reality. Afun Interactive creates digital content tailored to the specific needs of its clients, serving the entertainment industry by providing high-quality animations and graphics for movies and games. Through its innovative approach, the company aims to deliver immersive experiences and enhance the visual storytelling capabilities of its partners.

Neofect

Post in 2019
Neofect Co. Ltd, founded in 2010 by Hoyoung Ban, Scott Kim, and Young Choi, is a South Korean company focused on developing innovative rehabilitation training products and services for patients with neurological and musculoskeletal injuries. Its flagship product, the RAPAEL Smart Glove, was introduced in 2014 and has received FDA clearance, gaining traction among home patients and hospitals worldwide, including prominent institutions like NewYork-Presbyterian and the Department of Veterans Affairs. In addition to the Smart Glove, Neofect offers a range of products such as the RAPAEL Smart Pegboard, RAPAEL Smart Board, and RAPAEL Smart Kids. The company has also engaged in research, including a study with the National Rehabilitation Center in Korea that demonstrated the effectiveness of virtual reality-based rehabilitation combined with traditional therapy for stroke patients. Neofect operates offices in South Korea, the U.S., and Germany, with its products available in those regions and across Europe.

Buffett Seoul

Series A in 2019
Buffett Seoul is a company based in Seoul, South Korea, founded in 2017, specializing in group physical training services. It aims to deliver a distinctive fitness experience by offering an optimized group matching service tailored to individuals' physiques, exercise levels, and goals. This approach allows users to access customized fitness programs that seamlessly integrate offline classes with online home training, enhancing the overall effectiveness and personalization of their fitness journey.

IVIM Technology

Venture Round in 2019
IVIM Technology, founded in 2017 and based in Daejeon, South Korea, specializes in developing and manufacturing advanced medical devices, particularly the IntraVital Microscopy platform. The company provides services such as live cell intravital imaging, repetitive intravital imaging, drug efficacy monitoring, delivery monitoring, and whole tissue 3D imaging. IVIM Technology's innovations focus on exploring cellular interactions within living organisms to understand complex human diseases better. Their technology is instrumental in analyzing the in vivo efficacy of new biopharmaceuticals, including immunological, cell, gene, and antibody therapeutic agents, at the cellular level.

1drop

Venture Round in 2019
1drop is a health technology company that develops biosensor-based mobile health care devices and diagnostic platforms. Its solutions use smartphone optics to detect health conditions from a single drop of blood, employing machine learning algorithms and lateral flow sensors to measure biomarkers such as anemia, gout, cholesterol, and glucose. The aim is to support disease prevention and ongoing healthcare management. Founded in 2017 and based in Seongnam-si, South Korea.

Anymedi

Venture Round in 2019
Anymedi Inc., headquartered in Seoul, South Korea, specializes in manufacturing personalized medical devices. The company's core business involves providing a comprehensive platform service that includes uploading medical images, creating 3D models for clinical use, and offering 3D printing services to produce patient-specific simulators, surgical guides, and implants tailored to treat various defects, disorders, and diseases.

MediaFront

Venture Round in 2019
MediaFront Inc. is a media production agency headquartered in Seoul, South Korea, established in 1998. The company specializes in creating a diverse range of content, including immersive virtual and augmented reality experiences, interactive media, and physical media. MediaFront focuses on developing innovative media experiences through a platform that integrates with global media networks and partnerships. This enables the company to deliver immersive media coverage and contribute to the evolving landscape of digital experiences, including the development of digital experience parks.

Medinno

Venture Round in 2019
Medinno Inc., established in 2016 and headquartered in Suwon, South Korea, specializes in the research and development of neural stem cell therapies derived from adult brain tissue. The company focuses on creating therapeutic agents for treating a wide array of degenerative neurological diseases, including hypoxic-ischemic encephalopathy, neonatal refractory brain diseases, severe intraventricular hemorrhages, stroke, and Alzheimer's disease. Medinno aims to enable physicians to effectively address these conditions through its innovative cell therapeutics.

Butfit Seoul

Venture Round in 2019
Butfit Seoul Co., Ltd., established in 2018, specializes in offering group circuit training sessions both online and offline from its headquarters in Seoul, South Korea. The company provides workout training programs and rewards through its digital platform, fostering a community of fitness enthusiasts.

PinotBio

Venture Round in 2019
PinotBio, founded in 2017, is a biotechnology company based in Suwon, South Korea. It specializes in the research and development of new small molecule drugs for ophthalmology and oncology fields.

Gelato Lab

Venture Round in 2019
Gelato Lab Inc. is an information technology company based in Seoul, South Korea, established in 2017. It specializes in developing an application focused on nail arts, which allows users to explore a variety of nail art designs. The platform offers a diverse selection of designs categorized by color, type, and filters, enabling customers to easily search for and select their preferred nail art and find suitable nail shops. Through its innovative approach, Gelato Lab aims to enhance the nail art experience for consumers.

Lumir

Venture Round in 2018
Lumir Inc. is a company that specializes in designing, developing, and selling thermoelectric LED lamps powered by cooking oil. Founded in 2018 and based in Seoul, South Korea, Lumir aims to address the global issue of lighting through innovative solutions. The company offers a diverse range of products, including table lamps, bulb lamps, and off-grid lamps, which are available for purchase online. By leveraging sustainable energy sources, Lumir seeks to provide eco-friendly lighting alternatives that can significantly impact communities with limited access to electricity.

Cupix

Series A in 2018
Founded in South Korea in 2015, Cupix specializes in AI-powered software that creates digital twins of physical spaces using affordable cameras. Its platform enables users to design, build, maintain structures virtually with realism and scalability.

Nearthlab

Series A in 2018
Nearthlab is a Seoul-based technology company that designs and develops autonomous drone systems and AI-powered software for safety inspections in wind and renewable energy sectors, with applications also in defense and public safety. Its products include NearthWIND Pro, an autonomous drone for wind turbine inspection; Zoomable, a cloud-based data platform for inspection data management and analysis; and NearthWIND Mobile, a mobile autonomous flight control solution. The company uses proprietary deep-learning algorithms enabling autonomous flight under low computing power and low-latency conditions, aiming to reduce inspection time from hours to minutes. It holds multiple patents in Korea and overseas and has received venture backing from leading Korean investors.

Tomocube

Venture Round in 2018
Tomocube designs and manufactures 3D optical microscopes that use holotomography to capture non-invasive, dye-free, real-time images of living cells and tissues. Its product line includes HT-1, HT-2, and HT-X1 models, along with software such as TomoAnalysis. The technology enables researchers in cell biology, regenerative medicine, immunology, and 3D biology to study dynamic cellular processes without sample preparation. Founded in 2015 and headquartered in Daejeon, South Korea, Tomocube serves the life science research and diagnostic markets.

Spark Biopharma

Venture Round in 2018
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring and developing new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. '

Wave

Venture Round in 2018
Wave Corporation, founded in 2018 and based in South Korea, develops a mobile video chat application designed to enhance social interactions among users. The application enables individuals to create chat rooms where they can engage in group video chats, play live party games, watch video clips, read webtoons, and share photos. By facilitating these activities, Wave aims to reduce the distance between people, allowing friends to connect and interact in a more engaging and entertaining manner.

PinotBio

Series A in 2017
PinotBio, founded in 2017, is a biotechnology company based in Suwon, South Korea. It specializes in the research and development of new small molecule drugs for ophthalmology and oncology fields.

Neofect

Series C in 2017
Neofect Co. Ltd, founded in 2010 by Hoyoung Ban, Scott Kim, and Young Choi, is a South Korean company focused on developing innovative rehabilitation training products and services for patients with neurological and musculoskeletal injuries. Its flagship product, the RAPAEL Smart Glove, was introduced in 2014 and has received FDA clearance, gaining traction among home patients and hospitals worldwide, including prominent institutions like NewYork-Presbyterian and the Department of Veterans Affairs. In addition to the Smart Glove, Neofect offers a range of products such as the RAPAEL Smart Pegboard, RAPAEL Smart Board, and RAPAEL Smart Kids. The company has also engaged in research, including a study with the National Rehabilitation Center in Korea that demonstrated the effectiveness of virtual reality-based rehabilitation combined with traditional therapy for stroke patients. Neofect operates offices in South Korea, the U.S., and Germany, with its products available in those regions and across Europe.

MediaFront

Seed Round in 2017
MediaFront Inc. is a media production agency headquartered in Seoul, South Korea, established in 1998. The company specializes in creating a diverse range of content, including immersive virtual and augmented reality experiences, interactive media, and physical media. MediaFront focuses on developing innovative media experiences through a platform that integrates with global media networks and partnerships. This enables the company to deliver immersive media coverage and contribute to the evolving landscape of digital experiences, including the development of digital experience parks.

Anymedi

Venture Round in 2017
Anymedi Inc., headquartered in Seoul, South Korea, specializes in manufacturing personalized medical devices. The company's core business involves providing a comprehensive platform service that includes uploading medical images, creating 3D models for clinical use, and offering 3D printing services to produce patient-specific simulators, surgical guides, and implants tailored to treat various defects, disorders, and diseases.

Catenoid

Series C in 2017
Catenoid, Inc. is a pioneering company based in Seoul, South Korea, recognized as the first to launch an online video platform in Korea. The company specializes in providing a comprehensive video technology as a service (VTaaS) solution, which integrates software, hardware, and network components associated with online video into a unified platform. Catenoid serves over 700 domestic and international clients across various sectors, including online education, video commerce, broadcasting, and corporate media. Its offerings enable businesses to access optimized video services tailored to their specific needs, streamlining the complexities of video technology and enhancing user experience.

RIDI

Series C in 2017
RIDI Corporation is South Korea’s one of the largest digital content publication & distribution companies, mainly known for vitalizing the Korean e-book industry as well as empowering the web novel, webcomic, animation, articles, and news media. RIDI believes that rich imagination and deep insight serve as nutrients to make the human mind fertile and delivers them through its digital contents.

PinotBio

Seed Round in 2017
PinotBio, founded in 2017, is a biotechnology company based in Suwon, South Korea. It specializes in the research and development of new small molecule drugs for ophthalmology and oncology fields.

Tomocube

Venture Round in 2017
Tomocube designs and manufactures 3D optical microscopes that use holotomography to capture non-invasive, dye-free, real-time images of living cells and tissues. Its product line includes HT-1, HT-2, and HT-X1 models, along with software such as TomoAnalysis. The technology enables researchers in cell biology, regenerative medicine, immunology, and 3D biology to study dynamic cellular processes without sample preparation. Founded in 2015 and headquartered in Daejeon, South Korea, Tomocube serves the life science research and diagnostic markets.

RIDI

Series D in 2016
RIDI Corporation is South Korea’s one of the largest digital content publication & distribution companies, mainly known for vitalizing the Korean e-book industry as well as empowering the web novel, webcomic, animation, articles, and news media. RIDI believes that rich imagination and deep insight serve as nutrients to make the human mind fertile and delivers them through its digital contents.

Lumir

Venture Round in 2016
Lumir Inc. is a company that specializes in designing, developing, and selling thermoelectric LED lamps powered by cooking oil. Founded in 2018 and based in Seoul, South Korea, Lumir aims to address the global issue of lighting through innovative solutions. The company offers a diverse range of products, including table lamps, bulb lamps, and off-grid lamps, which are available for purchase online. By leveraging sustainable energy sources, Lumir seeks to provide eco-friendly lighting alternatives that can significantly impact communities with limited access to electricity.

ST Unitas

Series B in 2015
ST Unitas Co. Ltd. is an EduTech company based in Seoul, South Korea, that specializes in creating educational content and programs aimed at facilitating university entrance exam preparation, job searching, and language acquisition. Founded in 2010 and formerly known as ST & Company, the company operates branches across various regions in South Korea, including Busan, Incheon, and Gyeonggi-do. ST Unitas offers a diverse range of learning applications, such as "Connect," which provides courses on academics, diet, reading, fashion, and life skills. The company emphasizes collaboration with non-profit organizations, social enterprises, governments, and global entities to enhance educational outcomes and foster a positive societal impact. ST Unitas is driven by a vision of creating innovative content that contributes to personal and community development, prioritizing meaningful goals over mere profitability.

Zigbang

Venture Round in 2015
Founded in Seoul, South Korea in 2010, Zigbang operates a property listing platform and application that connects real estate agents with renters. It offers an apartment hunting service, enabling users to search for rental properties based on criteria such as number of rooms, occupants, and price.

GPCR Therapeutics

Venture Round in 2015
GPCR Therapeutics is a clinical-stage international biopharmaceutical company that develops therapeutics based on proprietary GPCR data. Founded in 2013 and headquartered in Seoul, South Korea, the company focuses on cancer by designing innovative drugs that target GPCR heteromers. It seeks to address unmet medical needs through novel approaches to GPCR targeting.

RIDI

Series B in 2014
RIDI Corporation is South Korea’s one of the largest digital content publication & distribution companies, mainly known for vitalizing the Korean e-book industry as well as empowering the web novel, webcomic, animation, articles, and news media. RIDI believes that rich imagination and deep insight serve as nutrients to make the human mind fertile and delivers them through its digital contents.

Ybrain

Series A in 2014
Founded in 2013, Ybrain specializes in developing wearable devices based on neurostimulation technology for treating neuropsychiatric disorders. Its primary focus is on Major Depressive Disorder (MDD) and other psychiatric illnesses, with ongoing clinical trials in South Korea.

Polygon Games

Series A in 2014
Polygon Games is a Korean game developer based in Seoul, specializing in online multiplayer games for global markets. Founded in 2008, the company is known for its development of ASTA: The War of Tears and Winds, an upcoming massively multiplayer online role-playing game. With a focus on creating engaging gaming experiences, Polygon Games aims to cater to diverse audiences worldwide.

ChannelBreeze

Series B in 2014
ChannelBreeze (채널브리즈) is a Korean company that provides social commerce services through an online platform including social network services. ChannelBreeze also provides search engine-based web services for real estate.

Iamcompany

Series A in 2014
Iamcompany is a South Korea-based student startup affiliated with the KAIST Midam committee, focusing on enhancing educational engagement through internet-based technologies. The company's primary objective is to unlock students' potential by bridging communication between educational institutions and caregivers. It has developed a mobile application, 'iamschool', which delivers news and updates from various educational institutions directly to students' caregivers, allowing them to follow and stay informed about their chosen institutions. Additionally, Iamcompany offers 'iamclass', a web service that directly communicates institutional information to caregivers while also advertising educational services to their target audience. By facilitating better information flow, Iamcompany aims to create a more supportive learning environment for students in South Korea.

NHN Edu

Seed Round in 2014
NHN Edu Corp. is an online educational services provider based in Seongnam, South Korea. The company specializes in designing and developing web and mobile platforms that enhance the educational experience. Its key offerings include IMS School, IMT, Union, and Pink Diary, which support teachers in managing classes and facilitating communication with parents. These platforms assist educators in monitoring student behavior and creating an effective learning environment. NHN Edu is committed to improving the quality of education through innovative technology solutions.

Zigbang

Series B in 2014
Founded in Seoul, South Korea in 2010, Zigbang operates a property listing platform and application that connects real estate agents with renters. It offers an apartment hunting service, enabling users to search for rental properties based on criteria such as number of rooms, occupants, and price.

Neofect

Series A in 2014
Neofect Co. Ltd, founded in 2010 by Hoyoung Ban, Scott Kim, and Young Choi, is a South Korean company focused on developing innovative rehabilitation training products and services for patients with neurological and musculoskeletal injuries. Its flagship product, the RAPAEL Smart Glove, was introduced in 2014 and has received FDA clearance, gaining traction among home patients and hospitals worldwide, including prominent institutions like NewYork-Presbyterian and the Department of Veterans Affairs. In addition to the Smart Glove, Neofect offers a range of products such as the RAPAEL Smart Pegboard, RAPAEL Smart Board, and RAPAEL Smart Kids. The company has also engaged in research, including a study with the National Rehabilitation Center in Korea that demonstrated the effectiveness of virtual reality-based rehabilitation combined with traditional therapy for stroke patients. Neofect operates offices in South Korea, the U.S., and Germany, with its products available in those regions and across Europe.

Perples

Venture Round in 2014
Perples, Inc. is a South Korean IT company founded in 2012, specializing in the development of Internet of Things technology. The company manufactures RECO, a Bluetooth-enabled beacon that facilitates proximity sensing and interaction with Bluetooth Low Energy (BLE) supported devices. This small wireless device enables store owners to engage with customers based on their geographic location within the store, allowing for the delivery of targeted promotions, coupon alerts, and relevant information to enhance the shopping experience. In addition to hardware, Perples develops software solutions focused on context targeting and event performance analysis, providing data-driven marketing solutions for enterprise customers.

Neofect

Venture Round in 2012
Neofect Co. Ltd, founded in 2010 by Hoyoung Ban, Scott Kim, and Young Choi, is a South Korean company focused on developing innovative rehabilitation training products and services for patients with neurological and musculoskeletal injuries. Its flagship product, the RAPAEL Smart Glove, was introduced in 2014 and has received FDA clearance, gaining traction among home patients and hospitals worldwide, including prominent institutions like NewYork-Presbyterian and the Department of Veterans Affairs. In addition to the Smart Glove, Neofect offers a range of products such as the RAPAEL Smart Pegboard, RAPAEL Smart Board, and RAPAEL Smart Kids. The company has also engaged in research, including a study with the National Rehabilitation Center in Korea that demonstrated the effectiveness of virtual reality-based rehabilitation combined with traditional therapy for stroke patients. Neofect operates offices in South Korea, the U.S., and Germany, with its products available in those regions and across Europe.

BioLeaders

Venture Round in 2012
BioLeaders Corporation is a healthcare company based in Yongin, South Korea, founded in 1999. The company focuses on developing innovative medicines, particularly in the field of oncology, with its flagship product being P53, an anti-cancer drug. BioLeaders is advancing several pipeline products, including BLS-H01, currently in phase 3 clinical trials for cervical cancer, and BLS-M07, which has completed phase 2b trials for the same condition. Additionally, the company is working on BLS-M22 for the treatment of Duchenne muscular dystrophy and BLC-H03, a vaccine adjuvant. Beyond pharmaceuticals, BioLeaders also offers health functional foods, raw materials, and functional cosmetic ingredients, positioning itself as a comprehensive provider in the healthcare sector.

LifeLiver

Venture Round in 2011
LifeLiver Co, Ltd is a biotechnology company based in Seongnam, South Korea, established in 2009. The company specializes in developing innovative treatments for severe liver diseases, focusing on its flagship product, the bioartificial liver system known as LifeLiver. This extracorporeal liver support system serves as a bridge to transplantation for patients who face delays in receiving timely liver transplants. In addition to LifeLiver, the company is involved in cell therapies such as HepaStem and H2Stem, aimed at treating conditions like non-alcoholic steatohepatitis and acute-on-chronic liver failure. LifeLiver has formed a strategic alliance with Promethera Biosciences SA to further advance its research and product development. As of March 2018, LifeLiver operates as a subsidiary of HLB Life Science Co., Ltd.

L&K Biomed

Venture Round in 2010
L&K Biomed Ltd. is a medical device company based in Seoul, South Korea, specializing in the research, development, manufacture, and sale of orthopedic spinal implants and other medical devices. Founded in 2008, the company offers a range of products for cervical and thoraco-lumbar spine procedures, including anterior cervical plate systems, posterior cervical fixation systems, and various types of spinal cages. In addition to its spinal products, L&K Biomed develops cardiovascular devices and cell simulation kits, catering to both domestic and international markets. The company's commitment to innovation in medical technology underscores its role in advancing healthcare solutions.

Abion

Venture Round in 2009
Abion Inc. is a biopharmaceutical company based in Seoul, South Korea, focused on the development of chemical and biological drugs and vaccines. Founded in 2007, the company is engaged in creating innovative anticancer therapies, including drug candidates like ABN401 for lung and stomach cancers, ABN501 as a biomarker for breast and ovarian cancers, and ABN201, a fusion protein targeting cancer cells. Abion also works on ABN101, an interferon-beta based drug aimed at treating autoimmune diseases affecting the central nervous system. Additionally, the company is developing ABN701, a vaccine designed to protect against staphylococcal enterotoxin B, and ABN601, a drug intended to safeguard the immune system from acute radiation syndrome. Abion's commitment to advancing companion diagnostic-based medicine positions it as a key player in the global biopharmaceutical market.

BNC Korea

Venture Round in 2009
BNC Korea Co., Ltd. is a South Korean company based in Daegu that specializes in the research, development, production, and sale of biomaterials. Founded in 2007, it focuses on creating products for the beauty and medical markets, including a range of hyaluronic acid fillers and skin boosters designed to temporarily reduce facial wrinkles. Notable products include Cutegel, Cutegel Lidocaine, and various skin treatment solutions such as face mask gels and brightening peeling gels. Additionally, BNC Korea manufactures medical products like Hibarry, which aids in wound care, and GENTA Q, a collagen sponge for wound protection. The company exports its innovative offerings to 45 countries, demonstrating its commitment to enhancing both aesthetic and therapeutic applications in the field of biomaterials.

MEKICS

Venture Round in 2008
MEKICS CO., Ltd is a medical device company based in Paju, South Korea, established in 1998. The company specializes in the design, manufacture, and sale of intensive care unit equipment globally. Its product range includes respiratory treatment devices such as artificial respirators, medical ventilators, patient monitors, and pulse oximeters. MEKICS also offers home healthcare solutions, including the rental of devices for patients with chronic respiratory conditions and the development of continuous positive airway pressure instruments for sleep apnea treatment. Additionally, the company provides a sleep apnea monitoring service through an online and mobile application, enhancing patient care in respiratory health.

Enzychem Lifesciences

Venture Round in 2008
Enzychem Lifesciences Corporation is a drug development company based in Seoul, South Korea, founded in 1999. The company specializes in the development, production, and marketing of active pharmaceutical ingredients (APIs) and functional health foods. Enzychem Lifesciences operates two GMP manufacturing plants and a global new drug research and development center located at KAIST in Daejeon. It focuses on creating therapies using its proprietary EC-18 technology platform to address various medical conditions, including chemotherapy-induced neutropenia, oral mucositis resulting from chemoradiation therapy, asthma, psoriasis, rheumatoid arthritis, atopic dermatitis, sepsis, and acute radiation syndrome. Additionally, the company manufactures veterinary medicines in various forms, including tablets, capsules, syrups, injections, ointments, and solutions aimed at diagnosing and preventing a range of diseases.

ADM Korea

Venture Round in 2008
ADM Korea is a clinical services company providing end-to-end support for pharmaceutical development. Its offerings include regulatory affairs, such as strategy consulting, registration dossier preparation, IND submissions, regulatory change reporting, and communications with regulatory authorities, along with comprehensive clinical trial services including project planning, protocol and case report form development, investigator recruitment, site selection, IRB submissions, staff training, trial management, monitoring, quality control and quality assurance, data management, statistical analysis, pharmacovigilance, medical translation, and e-CRF. Founded in 2003, ADM Korea is headquartered in Seoul, South Korea, and maintains regional offices in Japan, China, Taiwan, Singapore, and Korea, leveraging global CRO technology to support medical innovation.

Angiolab

Venture Round in 2008
Founded in 1999, Angiolab is a South Korean biotechnology company focused on developing medicines with angiogenesis inhibitors to treat various diseases. Its pipeline includes AL101 for non-alcoholic steatohepatitis (NASH), otitis media with effusion, periodontitis, psoriasis, age-related macular degeneration, abnormal obesity, and cancer.

Humasis

Venture Round in 2008
Humasis Co. Ltd. is a South Korean company specializing in the development, manufacturing, and marketing of in-vitro diagnostic products. Founded in 2000 and based in Anyang, the company focuses on point-of-care testing and offers a range of diagnostic solutions, including tests for cardiac markers, fertility hormones, infectious diseases, tumor markers, and cotinine. Their product lineup features pregnancy and ovulation self-test kits, as well as the Hubi-Quan Pro, a self-contained cartridge reader designed to deliver rapid and quantitative results for membrane-based lateral flow immunochromatographic assays. Humasis operates both in the domestic market and internationally, providing innovative rapid test kits for home and laboratory use.

Optrontec

Venture Round in 2008
Optrontec Inc. is a South Korean company operating in the optoelectronics industry, specializing in the development and manufacture of optical components. Founded in 1989 and headquartered in Changwon, the company produces a range of products including image sensing optical filters—such as reflective blue and absorptive IR cut-off filters, band pass filters, and absorptive film filters—suitable for applications in visible light, biometrics, and facial recognition. Additionally, Optrontec offers various optical lenses, including focus lenses and trifocal lenses, which serve industries such as automotive, life sciences, and defense. The company also provides modules and systems, including infrared filter assemblies and components for mobile cameras. Through its diverse product offerings, Optrontec supports advancements in imaging and sensing technologies across multiple sectors.

Micro Digital

Venture Round in 2008
Micro Digital is a South Korea-based biotechnology company that specializes in providing advanced systems for the biomedical and environmental industries. The company's product offerings include a Fully Automatic Immuno Analyzer, an Integrated Sample Banking Solution, a Microplate Luminometer, a Nano Spectrophotometer, and a Biomass Desiccation and Pulverization System. Through its innovative technologies, Micro Digital aims to enhance research and diagnostic capabilities in various biomedical applications.

Automobile & PCB

Venture Round in 2008
Automobile & PCB Inc. is a South Korean manufacturer specializing in printed circuit boards (PCBs). Established in 1977 and headquartered in Bucheon, the company produces a diverse range of PCB products, including thin PCBs for cellular phones and other portable electronics, build-up PCBs for mobile devices, and B.V.H PCBs for communication devices. Additionally, it offers multi-layer and double-sided PCBs for various applications in general electronics, home appliances, and communication systems. The company has expanded its operations internationally with branches in India and China. Formerly known as Quality & Technology Korea Co., Ltd., it rebranded to Automobile & PCB Inc. in 2009 and has achieved various quality certifications to enhance its market presence.

Carver Korea

Venture Round in 2008
Carver Korea Co., Ltd. is a prominent cosmetics manufacturer based in Seoul, South Korea, and operates as a subsidiary of Unilever PLC since November 2017. The company offers a diverse range of products, including skincare, makeup, and fashion items. Its well-known brands, such as A.H.C (Aesthetic Hydration Cosmetics), Shara Shara, and Vivito, encompass various skincare solutions like eye creams, essences, and toners. Additionally, Carver Korea provides women's apparel under the brand Lenouvelle. The company's products are distributed through multiple channels, including home shopping television networks, retail stores, duty-free shops, beauty salons, skincare clinics, and e-commerce platforms, catering to consumers across Korea.

Aprogen Healthcare & Games

Venture Round in 2008
Aprogen Healthcare & Games Inc. is a South Korean company based in Seongnam, founded in 1998. The company specializes in the development of medicines utilizing biomedical technology and offers innovative wireless communication solutions, including a remote lighting monitoring and control system for streetlights and security lamps. In addition to its healthcare and technology services, Aprogen is also involved in the mobile gaming industry, publishing popular games such as Dragon Raja M, Legendary Heroes, Heroes & Titans, and Flame Shadow. The company's diverse portfolio reflects its commitment to integrating healthcare, technology, and entertainment.

Cowin

Venture Round in 2007
Cowin manufactures automation systems for the design of semiconductor and LCD equipment. The company sells display panels and photomask repair equipment, as well as optical semiconductor inspection equipment, to businesses in China, Japan, and South Korea.

HUNESION

Venture Round in 2005
Hunesion Co., Ltd, founded in 2006 and based in Seoul, South Korea, develops and supplies a range of IT security solutions. The company's offerings include i-oneNet, a secure data transmission solution; i-oneNet DD, which provides one-way physical network connectivity; i-Spector for network traffic collection and analysis; TresDM, an intelligent malware detection solution; NGS for system access control and account management; CamPASS, a CCTV password management solution; MoBiCa, an enterprise mobile device management solution; and ViSiCa, a visit and safety management solution. Hunesion focuses on addressing various aspects of IT security to enhance data protection and system integrity.

Payletter

Venture Round in 2003
Payletter Inc. is a company that specializes in online billing and payment services, serving clients across North America, Europe, and Asia. Founded in 2001 and headquartered in Seoul, South Korea, Payletter offers solutions like BillOneQ, which tracks digital content usage, including fixed amounts, time of use, and recurring charges, catering specifically to gaming, PC rooms, and digital products. Additionally, the company provides payoneQ, an integrated payment agent service designed to facilitate secure transactions. Payletter's platform is equipped with advanced security features, such as SSL support and AES encryption, ensuring efficient and secure payment solutions for its users, particularly in the gaming and digital content sectors.

Mobiis

Venture Round in 2002
Mobiis Co., Ltd. is a South Korean company based in Seongnam that specializes in designing and building equipment and systems for monitoring and controlling particle accelerator beams and related technologies. Founded in 2000, Mobiis offers a range of products, including control systems and equipment such as low-level radio frequency amplifiers, solid-state amplifiers, undulator controllers, and step motor controllers. The company also develops control systems for nuclear fusion reactors, incorporating services like control data access, communication frameworks, central interlock systems, and coil power supply systems. Additionally, Mobiis is involved in computer programming, system integration, and engineering services, providing intelligent control solutions across various sectors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.